Stammdaten
BioRegenx, Inc. develops, manufactures, and sells medical test equipment and science-based nutritional products in the United States and internationally. The company offers Endocalyx Pro, a dietary supplement targeting microvascular capillary health and a range of other supplements under the MyBodyRx brand name; GlycoCheck software; and other health and wellness devices, such as pulsed electro-magnetic field devices, as well as StimaWELL and ReLounge, an electronic muscle stimulation therapy device; and markets hydrogen water products. It also develops TruScan.Ai mobile app/website that integrates additional health indicators; and VitalWellness app, which merge its DNA and epigenetics platform. In addition, the company operates a social media content management platform, including its interactive search engine. Further, it provides DocSun Artificial Intelligence (AI) Engine, which integrates advanced ballistocardiography that detects an individual's heartbeat without touch; photoplethysmography, a method that uses light to track the flow of blood; and distributes wellness devices. The company sells its products through a direct selling channel to health professionals and research organizations. BioRegenx, Inc. is headquartered in Chattanooga, Tennessee.
Unternehmen & Branche
| Name | BIOREGENX, INC. |
|---|---|
| Ticker | BRGX |
| CIK | 0001593184 |
| Sektor | Healthcare |
| Industrie | Medical - Healthcare Information Services |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
| Marktkapitalisierung | 8,7 Mio. USD |
| Beta | -2,87 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 1,854,513 | -1,543,569 | 0.00 | 410,986 | -4,537,254 |
| 2025-09-30 | 10-Q | 507,755 | -80,565 | 0.00 | 1,167,764 | -3,647,136 |
| 2025-06-30 | 10-Q | 445,970 | -178,345 | 0.00 | 1,150,558 | -3,654,708 |
| 2025-03-31 | 10-Q | 515,147 | -266,854 | 0.00 | 482,623 | -3,558,924 |
| 2024-12-31 | 10-K | 2,340,106 | -23,054,017 | -0.03 | 508,535 | -3,379,259 |
| 2024-09-30 | 10-Q | 596,037 | -394,860 | 0.00 | 17,361,364 | 13,560,770 |
| 2024-06-30 | 10-Q | 734,032 | -1,106,128 | 0.00 | 17,890,868 | 14,221,236 |
| 2024-03-31 | 10-Q | 549,548 | -3,152,458 | 0.00 | 15,085,299 | |
| 2023-12-31 | 10-K | 3,411,415 | -3,600,082 | -0.01 | 865,750 | -2,071,427 |
| 2023-09-30 | 10-Q | 794,544 | -2,519,035 | 0.00 | 33,981 | -2,798,005 |
| 2023-06-30 | 10-Q | 863,278 | -594,461 | 0.00 | 85,506 | -2,580,662 |
| 2023-03-31 | 10-Q | 5,552 | -548,033 | 0.00 | 77,989 | -2,415,246 |
| 2022-12-31 | 10-K | 42,159 | -78,308 | 0.00 | 59,149 | -2,527,938 |
| 2022-09-30 | 10-Q | 11,283 | -2,191 | 0.00 | -196,007 | |
| 2022-06-30 | 10-Q | 14,258 | -33,263 | 0.00 | -214,216 | |
| 2022-03-31 | 10-Q | 7,704 | -37,319 | 0.00 | -101,553 | |
| 2021-12-31 | 10-K | 198,584 | -96,873 | 0.00 | 127,762 | -84,234 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.